Smith, Moore & Co. Ishares Biotechnology ETF Transaction History

Smith, Moore & Co.

$1.17 Billion
Q3 2025

A detailed history of Smith, Moore & Co. transactions in Ishares Biotechnology ETF stock. As of the latest transaction made, Smith, Moore & Co. holds 4,675 shares of IBB stock, worth $767,588. This represents 0.06% of its overall portfolio holdings.

Number of Shares

4,675

Previous 4,935 5.27%

Holding current value

$767,588

Previous $624,000 8.01%

% of portfolio

0.06%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$127.63 - $144.37 $33,183 - $37,536	-260 Reduced 5.27%	4,675 $674,000
Q2 2025 Aug 13, 2025	SELL	$112.02 - $129.0 $19,603 - $22,575	-175 Reduced 3.42%	4,935 $624,000
Q1 2025 May 14, 2025	SELL	$127.9 - $140.56 $6,395 - $7,028	-50 Reduced 0.97%	5,110 $653,000
Q3 2024 Nov 12, 2024	SELL	$135.09 - $149.47 $13,509 - $14,947	-100 Reduced 1.9%	5,160 $751,000
Q2 2024 Aug 14, 2024	BUY	$124.64 - $139.96 $19,817 - $22,253	159 Added 3.12%	5,260 $721,000

Q1 2024 May 10, 2024	SELL	$132.3 - $140.89 $26,327 - $28,037	-199 Reduced 3.75%	5,101 $699,000
Q4 2023 Feb 13, 2024	SELL	$112.41 - $137.03 $140,624 - $171,424	-1,251 Reduced 19.1%	5,300 $720,000
Q3 2023 Nov 14, 2023	SELL	$122.27 - $131.47 $11,004 - $11,832	-90 Reduced 1.36%	6,551 $801,000
Q2 2023 Aug 11, 2023	BUY	$125.53 - $133.58 $41,299 - $43,947	329 Added 5.21%	6,641 $843,000
Q1 2023 May 12, 2023	SELL	$121.97 - $137.23 $3,049 - $3,430	-25 Reduced 0.39%	6,312 $815,000
Q4 2022 Feb 13, 2023	SELL	$117.58 - $138.43 $2,939 - $3,460	-25 Reduced 0.39%	6,337 $831,000
Q3 2022 Nov 14, 2022	BUY	$113.42 - $134.82 $22,797 - $27,098	201 Added 3.26%	6,362 $744,000
Q1 2022 May 12, 2022	SELL	$119.6 - $152.37 $9,568 - $12,189	-80 Reduced 1.28%	6,161 $803,000
Q4 2021 Feb 08, 2022	BUY	$145.27 - $164.78 $22,516 - $25,540	155 Added 2.55%	6,241 $953,000
Q3 2021 Nov 12, 2021	BUY	$158.89 - $176.21 $70,388 - $78,061	443 Added 7.85%	6,086 $984,000
Q2 2021 Aug 10, 2021	SELL	$146.13 - $163.65 $100,537 - $112,591	-688 Reduced 10.87%	5,643 $971,000
Q1 2021 May 14, 2021	BUY	$146.68 - $172.6 $107,956 - $127,033	736 Added 13.15%	6,331 $953,000
Q4 2020 Feb 16, 2021	SELL	$130.38 - $157.31 $26,597 - $32,091	-204 Reduced 3.52%	5,595 $795,000
Q2 2020 Aug 10, 2020	BUY	$103.79 - $138.65 $33,731 - $45,061	325 Added 5.94%	5,799 $745,000
Q1 2020 May 15, 2020	BUY	$94.39 - $123.48 $24,541 - $32,104	260 Added 4.99%	5,474 $590,000
Q4 2019 Feb 07, 2020	SELL	$97.24 - $123.5 $38,896 - $49,400	-400 Reduced 7.13%	5,214 $628,000
Q3 2019 Nov 07, 2019	BUY	$99.3 - $105.55 $7,050 - $7,494	71 Added 1.28%	5,614 $559,000
Q2 2019 Aug 15, 2019	BUY	N/A	400 Added 7.78%	5,543 $605,000
Q1 2019 May 07, 2019	BUY	N/A	5 Added 0.1%	5,143 $614,000
Q4 2018 Feb 15, 2019	SELL	N/A	-586 Reduced 10.24%	5,138 $496,000
Q3 2018 Nov 15, 2018	BUY	N/A	1,296 Added 29.27%	5,724 $698,000
Q2 2018 Aug 14, 2018	BUY	N/A	247 Added 5.91%	4,428 $486,000
Q1 2018 May 14, 2018	BUY	N/A	759 Added 22.18%	4,181 $446,000
Q4 2017 Feb 09, 2018	BUY	N/A	2,283 Added 200.44%	3,422 $365,000
Q3 2017 Nov 02, 2017	BUY	N/A	1,139	1,139 $380,000

Others Institutions Holding IBB

# of Institutions

964

Shares Held

31.6M

Call Options Held

3.52M

Put Options Held

2.74M

View Full List

About ISHARES BIOTECHNOLOGY ETF

Ticker IBB
Sector ETFs
Industry ETFs

More about IBB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Moore & Co., based on Form 13F filings with the SEC.

News

Stay updated on Smith, Moore & Co. with notifications on news.

Account